Biomark Diagnostics Inc.

OTCPK:BMKD.F Stock Report

Market Cap: US$10.4m

Biomark Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BMKD.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Nov 24BuyUS$157Guoyu HuangIndividual1,000US$0.16
28 Nov 24BuyUS$328Rashid Ahmed BuxIndividual2,000US$0.16
22 Nov 24BuyUS$826Rashid Ahmed BuxIndividual5,500US$0.15
21 Nov 24BuyUS$645Guoyu HuangIndividual4,500US$0.14
15 Nov 24BuyUS$170Rashid Ahmed BuxIndividual1,020US$0.17
15 Nov 24BuyUS$334Guoyu HuangIndividual2,000US$0.17
11 Nov 24BuyUS$997Guoyu HuangIndividual6,000US$0.17
08 Nov 24BuyUS$1,389Rashid Ahmed BuxIndividual8,400US$0.17
25 Oct 24BuyUS$678Guoyu HuangIndividual4,000US$0.17
10 Oct 24BuyUS$534Guoyu HuangIndividual3,000US$0.18
10 Sep 24BuyUS$92Rashid Ahmed BuxIndividual500US$0.18
10 Sep 24BuyUS$184Guoyu HuangIndividual1,000US$0.18
22 Aug 24BuyUS$2,351Rashid Ahmed BuxIndividual15,200US$0.15
22 Aug 24BuyUS$474Guoyu HuangIndividual3,000US$0.16
20 Aug 24BuyUS$32,265Guoyu HuangIndividual200,000US$0.16
20 Aug 24SellUS$32,265Bux Investments Ltd.Company200,000US$0.16
09 Aug 24BuyUS$830Guoyu HuangIndividual5,300US$0.16
09 Aug 24BuyUS$1,255Rashid Ahmed BuxIndividual7,800US$0.16
08 Aug 24BuyUS$196Guoyu HuangIndividual1,200US$0.16
01 Aug 24BuyUS$208Rashid Ahmed BuxIndividual1,200US$0.17
01 Aug 24BuyUS$354Guoyu HuangIndividual2,000US$0.18
25 Jul 24BuyUS$796Guoyu HuangIndividual5,000US$0.16
12 Jul 24BuyUS$1,105Rashid Ahmed BuxIndividual7,000US$0.16
11 Jul 24BuyUS$947Guoyu HuangIndividual6,000US$0.16
05 Jul 24BuyUS$299Rashid Ahmed BuxIndividual1,700US$0.18
04 Jul 24BuyUS$264Guoyu HuangIndividual1,500US$0.18
21 Jun 24BuyUS$123Rashid Ahmed BuxIndividual700US$0.18
20 Jun 24BuyUS$263Guoyu HuangIndividual1,500US$0.18
14 Jun 24BuyUS$349Guoyu HuangIndividual2,000US$0.17
08 Jun 24BuyUS$669Guoyu HuangIndividual4,000US$0.17
07 Jun 24BuyUS$408Rashid Ahmed BuxIndividual2,600US$0.16
30 May 24BuyUS$1,642Guoyu HuangIndividual10,200US$0.16
29 May 24BuyUS$161Rashid Ahmed BuxIndividual1,000US$0.16
24 May 24BuyUS$165Guoyu HuangIndividual1,000US$0.16
23 May 24BuyUS$698Rashid Ahmed BuxIndividual4,250US$0.16
16 May 24BuyUS$2,151Rashid Ahmed BuxIndividual10,800US$0.21
16 May 24BuyUS$808Guoyu HuangIndividual4,000US$0.21
01 May 24BuyUS$313Rashid Ahmed BuxIndividual1,500US$0.21
01 May 24BuyUS$418Guoyu HuangIndividual2,000US$0.21
25 Apr 24BuyUS$175Rashid Ahmed BuxIndividual800US$0.22
19 Apr 24BuyUS$162Rashid Ahmed BuxIndividual750US$0.22
18 Apr 24BuyUS$2,043Guoyu HuangIndividual10,500US$0.20
18 Apr 24BuyUS$2,749Rashid Ahmed BuxIndividual13,800US$0.21
11 Apr 24BuyUS$811Rashid Ahmed BuxIndividual3,700US$0.22
11 Apr 24BuyUS$1,020Guoyu HuangIndividual5,000US$0.20
15 Mar 24BuyUS$244Rashid Ahmed BuxIndividual1,100US$0.22
08 Mar 24BuyUS$334Guoyu HuangIndividual1,500US$0.22
20 Feb 24BuyUS$115Rashid Ahmed BuxIndividual500US$0.23
08 Feb 24BuyUS$348Rashid Ahmed BuxIndividual1,600US$0.23
02 Feb 24BuyUS$212Rashid Ahmed BuxIndividual1,000US$0.22
23 Jan 24BuyUS$150Rashid Ahmed BuxIndividual750US$0.20
19 Jan 24BuyUS$215Rashid Ahmed BuxIndividual1,000US$0.22

Insider Trading Volume

Insider Buying: BMKD.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BMKD.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders6,144,7826.76%
General Public39,077,78143%
Private Companies45,663,66650.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 5 shareholders own 57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45.1%
Biomark Technologies Inc
41,004,167US$4.7m0%no data
5.32%
Guoyu Huang
4,830,712US$552.6k4.78%no data
4.67%
Bux Investments Ltd.
4,247,411US$485.8k0%no data
1.45%
Rashid Ahmed Bux
1,314,070US$150.3k1.3%no data
0.45%
Grg Consulting Ltd.
412,088US$47.1k-32.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 21:24
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biomark Diagnostics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution